<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is generally accepted that esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arises from a Barrett's metaplastic lesion </plain></SENT>
<SENT sid="1" pm="."><plain>Altered <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> expression has been demonstrated in tissue from patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> but the mechanisms regarding such changes are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="0" ids="3098">bile acid</z:chebi> <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> (DCA) alters many cell signaling pathways and is implicated in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> progression </plain></SENT>
<SENT sid="3" pm="."><plain>We have demonstrated that DCA disrupts Golgi structure and affects protein secretion and glycosylation processes in cell lines derived from <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium (HET-1A) and Barrett's metaplastic epithelium (QH) </plain></SENT>
<SENT sid="4" pm="."><plain>Cell surface expression of <z:chebi fb="0" ids="18154">glycans</z:chebi> was identified using carbohydrate-specific probes (wheat germ agglutinate, conconavalin A, peanut agglutinin, <z:chebi fb="0" ids="16325">lithocholic acid</z:chebi> and Ulex europaeus agglutinin) that monitored N-glycosylation, O-glycosylation and core fucosylation in resting and DCA-treated cells </plain></SENT>
<SENT sid="5" pm="."><plain>DCA altered intracellular localization and reduced cell surface expression of <z:chebi fb="0" ids="17411">N-acetyl-D-glucosamine</z:chebi>, Î±-<z:chebi fb="36" ids="29309">methyl</z:chebi>-mannopyranoside (Man/<z:chebi fb="0" ids="17234">Glc</z:chebi>) and <z:chebi fb="0" ids="33984">fucose</z:chebi> in both cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, DCA reduced the expression of epithelial growth factor receptor and E-cadherin in a manner analogous to treatment of cells with the N-glycan biosynthesis inhibitor tunicamycin </plain></SENT>
<SENT sid="7" pm="."><plain>This is the first study to identify an altered Golgi structure and glycomic profile in response to DCA in esophageal epithelial cells, a process which could potentially contribute to <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C0546837,C0152018" disease_type="Neoplastic Process" abbrv="">cancer of the esophagus</z:e> </plain></SENT>
</text></document>